SYRE vs GILD: Which Stock is Better?
Side-by-side comparison of Spyre Therapeutics Inc. and Gilead Sciences Inc in 2026
SYRE
Spyre Therapeutics Inc.
—
GILD
Gilead Sciences Inc
$129.61
Key Metrics Comparison
| Metric | SYRE | GILD | Winner |
|---|---|---|---|
| Market Cap | $7.60B | $160.15B | GILD |
| P/E Ratio | N/A | 17.55 | GILD |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze SYRE
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is SYRE or GILD a better investment?
Comparing SYRE and GILD: Spyre Therapeutics Inc. has a market cap of $7.60B while Gilead Sciences Inc has $160.15B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between SYRE and GILD?
SYRE (Spyre Therapeutics Inc.) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: SYRE or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: SYRE or GILD?
Both SYRE and GILD show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: SYRE or GILD?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: SYRE or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $160.15B compared to $7.60B for SYRE.
Should I buy SYRE or GILD in 2026?
Both SYRE and GILD have investment merit. SYRE trades at $N/A while GILD trades at $129.61. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between SYRE and GILD stock?
Key differences: Market Cap ($7.60B vs $160.15B), P/E Ratio (N/A vs 17.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy SYRE or GILD in 2026?
The choice between SYRE and GILD depends on your investment goals. GILD shows higher revenue growth (0.0%). GILD has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between SYRE and GILD?
SYRE (Spyre Therapeutics Inc.) has a market cap of $7.60B, while GILD (Gilead Sciences Inc) has a market cap of $160.15B. GILD is the larger company by market value.